GlassScriptPhysician profile
Margaret P Amos
NPI 1932361870
$2,274.31
in general payments reported to CMS, 2019-2025
24 companies · $440 in 2025
The $440 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $208 · 2021: $245 · 2022: $589 · 2023: $340 · 2024: $347 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,028 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,028.12 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $270.91 | 2022-2025 | |
| Astellas Pharma US INC | $248.73 | 2019-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $233.95 | 2019-2023 | |
| Organon LLC | $167.65 | 2021-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $160.27 | 2019-2025 | Gardasil 9, Gardasil |
| Exeltis, USA INC. | $160.19 | 2020-2024 | Slynd |
| Pfizer INC. | $113.26 | 2019-2024 | |
| Sage Therapeutics, LLC | $105.64 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $104.90 | 2021-2024 | Paragard T 380a |
| Avion Pharmaceuticals | $97.94 | 2020-2021 | |
| Shield Therapeutics INC | $86.11 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $83.45 | 2020-2024 | Thinprep 2000 Processor |
| Channel Medsystems, INC. | $82.83 | 2022 | |
| Therapeuticsmd, INC. | $66.38 | 2019-2021 | |
| Sumitomo Pharma America, INC. | $49.84 | 2025 | Myfembree |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $42.57 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.78 | 2022 | |
| Medtronic, INC. | $40.40 | 2022-2024 | V-Loc 180 |
| Evofem Biosciences, INC. | $33.69 | 2022 | |
| C. R. Bard, INC. & Subsidiaries | $19.33 | 2022 | |
| Teleflex LLC | $19.28 | 2022 | |
| Supernus Pharmaceuticals, INC. | $18.18 | 2025 | Qelbree |
| Minerva Surgical, INC | $14.41 | 2025 | |
| Caldera Medical, INC | $12.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Margaret Amos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.